{"id":1821,"date":"2025-09-16T08:18:03","date_gmt":"2025-09-16T08:18:03","guid":{"rendered":"https:\/\/sitefansalaran.ir\/En\/?p=1821"},"modified":"2025-09-16T08:18:03","modified_gmt":"2025-09-16T08:18:03","slug":"novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics","status":"publish","type":"post","link":"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/","title":{"rendered":"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics"},"content":{"rendered":"

Swiss drugmaker Novartis (NOVN.S), opens new tab and drug developer Monte Rosa Therapeutics (GLUE.O), opens new tab agreed to an up to $5.7 billion licensing deal to develop treatments for immune-related diseases, the companies said on Monday, marking their second partnership in less than a year.<\/p>\n

Under the agreement, Monte Rosa will receive $120 million upfront and could earn additional milestone payments and royalties.
\nShares of the Boston based company jumped 50% in early morning trading after the announcement.<\/p>\n

Immune-related diseases occur when the immune system mistakenly attacks healthy tissues, causing inflammation and damage. These hard-to-treat conditions can severely impact patients’ quality of life.<\/p>\n

The deal grants Novartis exclusive rights to an undisclosed drug discovery target and options to license two additional programs from Monte Rosa\u2019s early stage immunology portfolio.<\/p>\n

The agreement represents “additional validation” of Monte Rosa’s molecular glue degrader discovery platform from an existing large pharma partner, Wedbush\u2019s Robert Driscoll said.<\/p>\n

Monte Rosa\u2019s platform, QuEEN, uses artificial intelligence and machine learning to discover and develop new degraders – small molecules designed to break down disease-causing proteins – which Novartis will take into clinical development and commercialisation.<\/p>\n

The deal allows Monte Rosa to leverage Novartis’ development capabilities to drive programs forward, and use the cash to achieve important milestones with its wholly-owned pipeline, Driscoll added.<\/p>\n

Last year, the companies signed a similar $150 million upfront deal for MRT-6160, an early-stage autoimmune\/inflammatory drug, with potential future payments up to $2.1 billion plus royalties on non-U.S. sales.<\/p>\n

The agreement is Novartis\u2019 second major deal this month, after an up to $5.2 billion tie up with China\u2019s Argo Biopharmaceutical for experimental heart drugs.<\/p>\n

Monte Rosa shares had fallen about 31% year-to-date till Friday close.<\/p>\n","protected":false},"excerpt":{"rendered":"

Swiss drugmaker Novartis (NOVN.S), opens new tab and drug developer Monte Rosa Therapeutics (GLUE.O), opens new tab agreed to an up to $5.7 billion licensing deal to develop treatments for immune-related diseases, the companies said on Monday, marking their second partnership in less than a year. Under the agreement, Monte Rosa will receive $120 million […]<\/p>\n","protected":false},"author":2,"featured_media":1822,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[498],"class_list":{"0":"post-1821","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sitefansalaran-industry-news","8":"tag-novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics"},"yoast_head":"\nNovartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics - sitefansalarn<\/title>\n<meta name=\"description\" content=\"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"sitefansalarn\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-16T08:18:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sitefansalaran.ir\/En\/wp-content\/uploads\/2025\/09\/photo_2025-09-16_11-49-13.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"975\" \/>\n\t<meta property=\"og:image:height\" content=\"618\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"dorost\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"dorost\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/\",\"url\":\"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/\",\"name\":\"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics - sitefansalarn\",\"isPartOf\":{\"@id\":\"https:\/\/sitefansalaran.ir\/En\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sitefansalaran.ir\/En\/wp-content\/uploads\/2025\/09\/photo_2025-09-16_11-49-13.jpg\",\"datePublished\":\"2025-09-16T08:18:03+00:00\",\"author\":{\"@id\":\"https:\/\/sitefansalaran.ir\/En\/#\/schema\/person\/683165262506af1443eb7897426c3ac4\"},\"description\":\"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics\",\"breadcrumb\":{\"@id\":\"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/#primaryimage\",\"url\":\"https:\/\/sitefansalaran.ir\/En\/wp-content\/uploads\/2025\/09\/photo_2025-09-16_11-49-13.jpg\",\"contentUrl\":\"https:\/\/sitefansalaran.ir\/En\/wp-content\/uploads\/2025\/09\/photo_2025-09-16_11-49-13.jpg\",\"width\":975,\"height\":618},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/sitefansalaran.ir\/En\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sitefansalaran.ir\/En\/#website\",\"url\":\"https:\/\/sitefansalaran.ir\/En\/\",\"name\":\"sitefansalarn\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sitefansalaran.ir\/En\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/sitefansalaran.ir\/En\/#\/schema\/person\/683165262506af1443eb7897426c3ac4\",\"name\":\"dorost\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sitefansalaran.ir\/En\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9e1aef8b9f557ebfb9bc35a62b323041f36a130f4ef6ef775b3cdb80a3cfc4a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9e1aef8b9f557ebfb9bc35a62b323041f36a130f4ef6ef775b3cdb80a3cfc4a?s=96&d=mm&r=g\",\"caption\":\"dorost\"},\"url\":\"https:\/\/sitefansalaran.ir\/En\/author\/adminsitefan\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics - sitefansalarn","description":"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics","og_description":"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics","og_url":"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/","og_site_name":"sitefansalarn","article_published_time":"2025-09-16T08:18:03+00:00","og_image":[{"width":975,"height":618,"url":"https:\/\/sitefansalaran.ir\/En\/wp-content\/uploads\/2025\/09\/photo_2025-09-16_11-49-13.jpg","type":"image\/jpeg"}],"author":"dorost","twitter_card":"summary_large_image","twitter_misc":{"Written by":"dorost","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/","url":"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/","name":"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics - sitefansalarn","isPartOf":{"@id":"https:\/\/sitefansalaran.ir\/En\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/sitefansalaran.ir\/En\/wp-content\/uploads\/2025\/09\/photo_2025-09-16_11-49-13.jpg","datePublished":"2025-09-16T08:18:03+00:00","author":{"@id":"https:\/\/sitefansalaran.ir\/En\/#\/schema\/person\/683165262506af1443eb7897426c3ac4"},"description":"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics","breadcrumb":{"@id":"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/#primaryimage","url":"https:\/\/sitefansalaran.ir\/En\/wp-content\/uploads\/2025\/09\/photo_2025-09-16_11-49-13.jpg","contentUrl":"https:\/\/sitefansalaran.ir\/En\/wp-content\/uploads\/2025\/09\/photo_2025-09-16_11-49-13.jpg","width":975,"height":618},{"@type":"BreadcrumbList","@id":"https:\/\/sitefansalaran.ir\/En\/2025\/09\/16\/novartis-signs-up-to-5-7-billion-licensing-deal-with-monte-rosa-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sitefansalaran.ir\/En\/"},{"@type":"ListItem","position":2,"name":"Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/sitefansalaran.ir\/En\/#website","url":"https:\/\/sitefansalaran.ir\/En\/","name":"sitefansalarn","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sitefansalaran.ir\/En\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/sitefansalaran.ir\/En\/#\/schema\/person\/683165262506af1443eb7897426c3ac4","name":"dorost","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sitefansalaran.ir\/En\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e9e1aef8b9f557ebfb9bc35a62b323041f36a130f4ef6ef775b3cdb80a3cfc4a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9e1aef8b9f557ebfb9bc35a62b323041f36a130f4ef6ef775b3cdb80a3cfc4a?s=96&d=mm&r=g","caption":"dorost"},"url":"https:\/\/sitefansalaran.ir\/En\/author\/adminsitefan\/"}]}},"_links":{"self":[{"href":"https:\/\/sitefansalaran.ir\/En\/wp-json\/wp\/v2\/posts\/1821","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sitefansalaran.ir\/En\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sitefansalaran.ir\/En\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sitefansalaran.ir\/En\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/sitefansalaran.ir\/En\/wp-json\/wp\/v2\/comments?post=1821"}],"version-history":[{"count":1,"href":"https:\/\/sitefansalaran.ir\/En\/wp-json\/wp\/v2\/posts\/1821\/revisions"}],"predecessor-version":[{"id":1823,"href":"https:\/\/sitefansalaran.ir\/En\/wp-json\/wp\/v2\/posts\/1821\/revisions\/1823"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sitefansalaran.ir\/En\/wp-json\/wp\/v2\/media\/1822"}],"wp:attachment":[{"href":"https:\/\/sitefansalaran.ir\/En\/wp-json\/wp\/v2\/media?parent=1821"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sitefansalaran.ir\/En\/wp-json\/wp\/v2\/categories?post=1821"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sitefansalaran.ir\/En\/wp-json\/wp\/v2\/tags?post=1821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}